Our daily commitment: improving patients’ lives
"We keep strengthening our pipeline and building a better future for our patients and their families, while delivering a great performance for the company".
Roberto Tascione, CEO Zambon S.p.A.
Zambon is continually searching for solutions to improve the lives of patients affected by severe respiratory diseases such as CF, BOS and NCFB.
We have developed a wide range of treatment solutions for the most prevalent respiratory diseases.
We have developed a formula dedicated to treating moderate pain.
In the coming years, we will continue to invest in research aimed at improving the quality of life of Parkinson's patients.
We develop solutions that help treat simple infections of the urinary tract.
We continue to show significant progress in Research&Development, successfully reinforcing our collaborations with scientific communities and patient groups around the world.
Industrial Business Operations
Our plants in Italy, Switzerland, China and Brazil utilize consistent approach worldwide, delivering high-quality standardized products and using state of the art technological operations.
Zambon Business Development remains focused on early and late stage assets in our strategic Therapeutic Areas: CNS and Severe Respiratory Diseases.
Designed from the ruins of the previous industrial building, Z-LIFE the new home of Zambon Pharma, was created within the OpenZone campus to promote our approach based on sharing without boundaries and on our ability to transform ideas into tangible opportunities for patients.
Our growth will be driven by increasing further internationalization, maximizing our core products and gradually expand our focus on specialties like Parkinson’s Disease, BOS and NCFB.
Million euros in revenues
People around the world
Million Euros Net Income